At this in-person forum, we’ll explore emerging solutions to address policies and tactics that currently enable high drug prices.
Speakers will address
- Anticompetitive tactics
- Drug value and evidence
- Cell and gene therapies and GLP-1s
- Current federal policy discussions to lower the price of prescription drugs
Speakers
CEO, Initiative for Medicines, Access & Knowledge (I-MAK)
Executive Director, Campaign for Sustainable Drug Pricing (CSRxP).
Senior Vice President, Government Relations, Kaiser Permanente
Associate Executive Director, The Permanente Medical Group
Professor, Georgetown University Medical Center, Director, PharmedOut
Professor of Medicine, Harvard Medical School, Director, PORTAL
Executive Director, Kaiser Permanente Institute for Health Policy
Director, Leavitt Partners
Senior Health Counsel, US Senate Committee on Finance
Senior Fellow, Center on Health Policy, Brookings Institution